Picture of IO Biotech logo

IOBTQ IO Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Nov 7 (Reuters) - IO Biotech Inc IOBT.O:

IO BIOTECH PRESENTS PRE-CLINICAL DATA HIGHLIGHTING THE POTENTIAL OF ADDITIONAL THERAPEUTIC CANCER VACCINE CANDIDATES AT THE 2025 ANNUAL MEETING OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC)

Source text: ID:nGNX2R9Mcg

Further company coverage: IOBT.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on IO Biotech

See all news